These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1639 related items for PubMed ID: 9834044

  • 21. Comparison of hemodynamic responses to isoproterenol infusion and surgical stress in patients given cardioselective and noncardioselective beta-adrenergic antagonists.
    de Bruijn N, Reves JG, Croughwell N, Knopes K.
    Anesth Analg; 1987 Jul; 66(7):637-42. PubMed ID: 2886078
    [Abstract] [Full Text] [Related]

  • 22. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ.
    Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
    [Abstract] [Full Text] [Related]

  • 23. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [Abstract] [Full Text] [Related]

  • 24. [The effects of perioperative continuous administration of mivazerol on early postoperative hemodynamics and plasma catecholamines after major surgery].
    Apitzsch H, Olthoff D, Thieme V, Vetter B, Wiegel M.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Aug; 35(8):515-22. PubMed ID: 10992963
    [Abstract] [Full Text] [Related]

  • 25. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 26. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan 01; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 27. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease.
    Stewart RA, Raffel OC, Kerr AJ, Gabriel R, Zeng I, Young AA, Cowan BR.
    Circulation; 2008 Sep 02; 118(10):1041-6. PubMed ID: 18725484
    [Abstract] [Full Text] [Related]

  • 28. Plasma catecholamine and cardiovascular responses to nifedipine in hypertensives WHO-stage II.
    Lehmann M, Dürr H, Arratibel-Imaz I, Balle C, Keller E, Merkelbach H, Keul J.
    Arzneimittelforschung; 1989 Dec 02; 39(12):1593-6. PubMed ID: 2624611
    [Abstract] [Full Text] [Related]

  • 29. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb 02; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 30. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 02; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 31. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade.
    Blau A, Battler A, Eldar M, Rath S, Neufeld HN, Kapuler S, Iaina A, Cohen D, Eliahou HE.
    J Clin Hypertens; 1986 Mar 02; 2(1):13-20. PubMed ID: 2873210
    [Abstract] [Full Text] [Related]

  • 32. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S, Arita M, Ueno Y, Shiotani M, Nakatsu C, Nakamura Y, Hano T, Nishio I, Masuyama Y.
    J Cardiol; 1991 Mar 02; 21(1):115-24. PubMed ID: 1687786
    [Abstract] [Full Text] [Related]

  • 33. The influence of propranolol on the cardiovascular effects and plasma clearance of epinephrine.
    Ichinohe T, Igarashi O, Kaneko Y.
    Anesth Prog; 1991 Mar 02; 38(6):217-20. PubMed ID: 1842159
    [Abstract] [Full Text] [Related]

  • 34. Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study.
    Newton GE, Azevedo ER, Parker JD.
    Circulation; 1999 May 11; 99(18):2402-7. PubMed ID: 10318661
    [Abstract] [Full Text] [Related]

  • 35. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
    Tallaj J, Wei CC, Hankes GH, Holland M, Rynders P, Dillon AR, Ardell JL, Armour JA, Lucchesi PA, Dell'Italia LJ.
    Circulation; 2003 Jul 15; 108(2):225-30. PubMed ID: 12847066
    [Abstract] [Full Text] [Related]

  • 36. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
    Transpl Int; 2003 May 15; 16(5):313-20. PubMed ID: 12759722
    [Abstract] [Full Text] [Related]

  • 37. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M, Juhlin-Dannfelt A, Aström H.
    Clin Physiol; 1985 Jun 15; 5(3):231-42. PubMed ID: 2860992
    [Abstract] [Full Text] [Related]

  • 38. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM, MacDonald TM, Prasad N, Maclean D, Peebles L, McDevitt DG.
    QJM; 1995 Aug 15; 88(8):565-70. PubMed ID: 7648243
    [Abstract] [Full Text] [Related]

  • 39. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 15; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 40. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H, Pedersen OL, Dahlöf B, Kjeldsen SE, Lindholm LH.
    Ugeskr Laeger; 2003 Jan 27; 165(5):456-9. PubMed ID: 12599843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 82.